Centene's commercial business shrank 21% while Medicare cushioned the blow
Commercial revenue fell 21% from a year earlier, to $8.70 B, and the filing ties lower gross margin mainly to reduced Marketplace membership. Medicare rose 20% to $11.26 B and now sits second behind Medicaid. That swap in the top three is the quarter's real news, because it changes which business the company leans on when one segment stumbles. Medicare's gain came from drug-plan premiums and membership, while its Medicare Advantage membership fell. A reader should ask which of those gains will last.
Medicaid carries the company at 58% of revenue, by far the biggest share. Its revenue rose 6%, which the filing attributes to pass-through payments and rate increases, partly offset by lower membership. Its gross margin still slipped 0.3% as sales rose. Pass-through money is state money that flows through the books, so it inflates revenue without adding profit. That makes Medicaid's 6% look better than its margin does. Investors should read that margin line before the headline. The gap is wide enough to matter.
Commercial is not finished falling. The filing says Health Net will discontinue commercial group offerings in 2027, with policy end dates primarily between February 28, 2027 and December 28, 2027. That schedule means the revenue decline is not a one-quarter event. Investors should price in more of it. The next two annual reports will show how much membership is gone. Will Medicare's growth keep covering the Commercial decline once those policies end, or does the second-largest business start to slide?

